We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Hernia Patching System Is Easily Deployed

By HospiMedica staff writers
Posted on 18 Sep 2006
A new hernia repair platform provides three points of protection and tension-free repair, allowing the body's normal healing process to incorporate it into the local structures.

The Ultrapro hernia system (UHS) is a sterile, pre-shaped, three-dimensional device patch for the repair of abdominal wall defects. More...
The UHS consists of three attached components: an underlay patch that provides an effective posterior repair on the inside of the abdominal wall, a cylindrical mesh connector similar to a plug, and an onlay patch that lays flat over the abdominal wall.

The reinforced underlay patch enables the UHS to be easily deployed by the surgeon, while the lightweight construction provides for flexibility and enhanced patient comfort. The lightweight support was made possible by providing a mesh burst strength that is four times stronger than the maximum abdominal pressure and providing excellent tissue in-growth with a flexible scar.

The polymer of the undyed and dyed polypropylene fiber is identical to the material used for Prolene suture material. The onlay patch, connector, and underlay patch are manufactured from approximately equal parts of absorbable monocryl (poliglecaprone 25) fiber and non-absorbable Prolene fiber. The underlay patch is reinforced by a flat, undyed absorbable film of monocryl. According to the manufacturer, 50% less foreign material remains in the body compared with traditional hernia repair systems. The UHS must always be separated from the abdominal cavity by the peritoneum, and is not suitable for use as a plug.

The UHS is manufactured by Ethicon (Somerville, NJ, USA), a Johnson & Johnson company.

Inguinal hernias are by far the most common type of hernia to develop in adults, representing about two-thirds of these defects. They occur in a part of the abdominal wall known as the inguinal canal, and are much more common in men. A man's testicles descend through this area before birth, leaving a natural defect called the internal ring that can develop into a hernia if it doesn't seal properly. As a result, the contents of the abdomen, such as intestine, may protrude through the opening, creating pain and/or a bulge.



Related Links:
Ethicon

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.